CUSIP 640268306COM NEWNKTRQ4 2025
11 filings · latest Mar 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bvf Inc/Il | 1.56M | $65.94M |
| 2 | Vanguard Group Inc | 1.03M | $43.43M |
| 3 | Two Seas Capital LP | 745.2K | $31.51M |
| 4 | Blackrock, Inc. | 645.6K | $27.30M |
| 5 | Armistice Capital, LLC | 596.0K | $25.20M |
| 6 | Morgan Stanley | 566.4K | $23.95M |
| 7 | Prosight Management, LP | 554.6K | $23.45M |
| 8 | Two Sigma Investments, LP | 473.0K | $20.00M |
| 9 | Invesco Ltd. |
| 4 | Nov 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 2.2% | 418.5K | SEC |
| 5 | Nov 13, 2025 | Susquehanna Portfolio Strategies, LLC | 13G | 6.3% | 1.24M | SEC |
| 6 | Oct 31, 2025 | The Vanguard Group | 13G/A | 5.0% | 948.6K | SEC |
| 7 | Oct 28, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 571.0K | SEC |
| 8 | Aug 14, 2025 | Nantahala Capital Management, LLC | 13G | 5.7% | 709.8K | SEC |
| 9 | Jul 18, 2025 | Blackrock, Inc. | 13G/A | 1.6% | 203.0K | SEC |
| 10 | Jul 9, 2025 | Biotechnology Value Fund L P | 13G | 7.4% | 1.28M | SEC |
See the full Schedule 13D/13G history for Nektar Therapeutics.
Unlock full history| 468.2K |
| $19.79M |
| 10 | Millennium Management LLC | 454.1K | $19.20M |